Stocks360

China Jo-Jo Drugstores, Inc. (CJJD)

Stock analysis · NASDAQ · Healthcare · Medical - Pharmaceuticals

Share: Facebook X WhatsApp SMS
$1.52

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$9.95M
PE (TTM)
-0.52
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
-0.15
Day Range
$1.52 – $1.60
52-wk Range
$0.85 – $4.50
Avg Volume
N/A
Volume
5.86K

China Jo-Jo Drugstores, Inc. (CJJD) is a publicly traded company in the Healthcare sector. Latest price: $1.52. Market cap $9.95M. Trailing PE -0.52. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent
Jul 4, 2024
EPS $-1.96 vs est. $1.58
Missed by $3.54

Proprietary Signals

Signal snapshot temporarily unavailable.

About China Jo-Jo Drugstores, Inc.

China Jo-Jo Drugstores, Inc., along with its subsidiary entities, functions as a prominent retailer and distributor of a wide array of pharmaceutical and healthcare products across the People's Republic of China. Its operations are structured into four distinct segments: retail pharmacies, an online drugstore, wholesale drug distribution, and the cultivation of medicinal herbs. The company's brick-and-mortar stores supply customers with diverse pharmaceutical items, including both prescription and over-the-counter medications, nutritional supplements, traditional Chinese remedies, personal and family care products, and medical devices. Beyond these, they also stock everyday convenience goods such as consumables, seasonal items, and promotional merchandise. To further enhance customer service, these locations feature licensed practitioners of both Western and Traditional Chinese Medicine, available at scheduled times for consultations, examinations, and the treatment of common ailments. Additionally, China Jo-Jo Drugstores operates an internet-based pharmacy, marketing over-the-counter medications and health supplements directly to consumers, as well as leveraging third-party e-com…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)-0.52×
P/S (TTM)0.06×
P/B0.14×
P/FCF (TTM)-2.44×
EV / EBITDA26.91×

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Gross Margin20.13%
Operating Margin-2.29%
Net Margin-2.74%

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap